The Role of Xanthine Oxidase in Hemodialysis-Induced Oxidative Injury: Relationship with Nutritional Status

Table 1

Basic clinical and biochemical data of ESRD patients and controls.

	Control group; (𝑛 = 22)	ESRD patients; (𝑛 = 50)
Age (years)	58.9 ± 13.3	61.7 ± 10.7
Gender (male/female, 𝑛)	9/13	14/14
Hypertension (yes/no, 𝑛)	8/14	8/14
Hemodialysis vintage (months)	NA	46.3 ± 36.6
𝐾𝑡/𝑉 urea	NA	1.10 ± 0.37
Neutrophil leukocytes (10^9/L)	4.10 ± 1.92	4.89 ± 2.07
Lymphocytes (10^9/L)	2.21 ± 0.55	2.39 ± 0.92
Log CRP (mg/L)	0.114 ± 0.335	0.534 ± 0.633*
Albumin (g/L)	45.6 ± 5.1	40.6 ± 7.3*
Hemoglobin (g/L)	133.7 ± 20.2	118.6 ± 24.1*
Ferritin (𝜇g/L)	85 ± 62	511 ± 647*
Body mass index (kg/m^2)	22.9 ± 5.3	21.4 ± 4.4
GNRI	114.3 ± 16.0	105.9 ± 13.4
Total cholesterol (mmol/L)	4.65 ± 1.14	4.90 ± 0.96
HDL cholesterol (mmol/L)	1.76 ± 0.54	1.54 ± 0.51
LDL cholesterol (mmol/L)	2.75 ± 0.65	3.09 ± 0.62
Triglycerides (mmol/L)	1.92 ± 0.91	2.13 ± 0.77
Plasma atherogenic index	0.152 ± 0.175	0.196 ± 0.172

^∗𝑃 < 0.05 versus controls; NA: not applicable.